Unumed ApS
CVR number: 37458821
Tordenskjoldsgade 21, 1055 København K
emsa@unumed.com
tel: 31686191
www.unumed.com
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | - 431.35 | -1 389.31 | 59.33 | 5 113.06 | 8 002.28 |
Employee benefit expenses | -1 284.19 | -2 267.83 | -5 171.97 | -10 588.15 | -12 455.35 |
Total depreciation | - 224.41 | - 688.18 | -1 222.33 | -1 751.42 | -2 389.48 |
EBIT | -1 939.95 | -4 345.32 | -6 334.98 | -7 226.50 | -6 842.55 |
Other financial income | 166.19 | 220.62 | 273.39 | 369.68 | 475.11 |
Other financial expenses | 92.15 | - 178.77 | - 238.65 | - 658.59 | -2 193.74 |
Reduction non-current investment assets | 1 014.08 | -1 738.34 | -2 429.04 | -6 128.60 | -2 490.55 |
Pre-tax profit | - 851.83 | -6 041.80 | -8 729.27 | -13 644.01 | -11 051.73 |
Income taxes | 2 221.66 | 1 026.18 | 1 298.20 | 1 062.94 | 1 715.11 |
Net earnings | 1 369.82 | -5 015.62 | -7 431.07 | -12 581.08 | -9 336.62 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Development expenditure | 4 202.27 | 8 307.19 | 12 876.03 | 15 967.11 | 21 391.24 |
Intangible assets total | 4 202.27 | 8 307.19 | 12 876.03 | 15 967.11 | 21 391.24 |
Machinery and equipment | 6.47 | 35.85 | 34.26 | 50.93 | 106.29 |
Tangible assets total | 6.47 | 35.85 | 34.26 | 50.93 | 106.29 |
Holdings in group member companies | 349.63 | 803.21 | 803.21 | ||
Other receivables | 37.80 | 55.43 | 37.80 | 37.80 | 37.80 |
Investments total | 387.43 | 858.64 | 841.01 | 37.80 | 37.80 |
Non-curr. owed by group member comp. | 2 130.61 | 2 130.60 | 2 130.60 | ||
Long term receivables total | 2 130.61 | 2 130.60 | 2 130.60 | ||
Inventories total | |||||
Current trade debtors | 49.18 | ||||
Prepayments and accrued income | 16.72 | 16.49 | 4.20 | 7.67 | 52.58 |
Current other receivables | 113.58 | 166.81 | 291.02 | 86.24 | 348.03 |
Current deferred tax assets | 1 182.10 | 1 026.18 | 1 271.34 | 1 062.94 | 1 715.11 |
Short term receivables total | 1 312.40 | 1 209.48 | 1 566.55 | 1 156.86 | 2 164.89 |
Cash and bank deposits | 3 090.58 | 1 204.37 | 108.70 | 58.85 | 372.23 |
Cash and cash equivalents | 3 090.58 | 1 204.37 | 108.70 | 58.85 | 372.23 |
Balance sheet total (assets) | 11 129.76 | 13 746.13 | 17 557.16 | 17 271.55 | 24 072.44 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 65.04 | 73.32 | 77.49 | 76.70 | 76.70 |
Share premium account | 15 363.17 | ||||
Other reserves | 8 307.19 | 10 043.30 | 12 454.34 | 16 685.17 | |
Retained earnings | -14 485.40 | 4 109.61 | 2 493.22 | -4 234.17 | -21 046.06 |
Profit of the financial year | 1 369.82 | -5 015.62 | -7 431.07 | -12 581.08 | -9 336.62 |
Shareholders equity total | 2 312.64 | 7 474.49 | 5 182.95 | -4 284.19 | -13 620.81 |
Non-current loans from credit institutions | 2 047.29 | 6 428.15 | 17 800.95 | 33 546.89 | |
Non-current owed to group member | 224.16 | 101.01 | 105.05 | 105.05 | 109.26 |
Non-current accruals and deferred income | 774.00 | 814.72 | 648.00 | ||
Non-current deferred tax liabilities | 157.00 | 486.30 | 493.59 | 487.17 | 519.67 |
Non-current liabilities total | 381.16 | 2 634.60 | 7 800.80 | 19 207.89 | 34 823.82 |
Current loans from credit institutions | 2 408.43 | 608.39 | 380.00 | 1 280.00 | |
Current trade creditors | 156.41 | 386.00 | 382.82 | 291.69 | 245.58 |
Current owed to participating | 500.00 | 500.00 | 500.00 | ||
Other non-interest bearing current liabilities | 5 871.11 | 2 642.66 | 3 202.60 | 1 369.86 | 677.14 |
Accruals and deferred income | 108.00 | 186.29 | 166.72 | ||
Current liabilities total | 8 435.95 | 3 637.04 | 4 573.41 | 2 347.84 | 2 869.43 |
Balance sheet total (liabilities) | 11 129.76 | 13 746.13 | 17 557.16 | 17 271.55 | 24 072.44 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.